“Clinical trials referral resource. Clinical trials using pyrazoloacridine (PZA),”, Oncology, vol. 11, pp. 991-94, 1997.
, “Clinical trials referral resource. Clinical trials with perillyl alcohol.”, Oncology (Williston Park), vol. 11, no. 12, p. 1817, 1820, 1997.
, “Clinical Trials Referral Resource. Clinical trials with prillyl alcohol.”, Oncology, vol. 11, pp. 1817-23, 1997.
, “Clinical trials referral resource. Clinical trials with PSC-833”, Oncology, vol. 11, pp. 490-3, 1997.
, “Clinical trials referral resource. Clinical trials with PSC-833.”, Oncology (Williston Park), vol. 11, no. 4, p. 490, 493, 1997.
, “Clinical trials referral resource. Clinical trials with pyrazoloacridine.”, Oncology (Williston Park), vol. 11, no. 7, pp. 991-4, 1997.
, “Clinical trials referral resource. High priority trials.”, Oncology, vol. 11, pp. 1144-50, 1997.
, “Clinical Trials Referral Resource. Lung cancer.”, Oncology, vol. 11, pp. 1686-94, 1997.
, “Clinical Trials Referral Resource. Trials using tumor vaccines.”, Oncology (Williston Park), vol. 11, no. 1, pp. 81-2, 84, 90, 1997.
, , , , “Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.”, J Clin Oncol, vol. 15, no. 5, pp. 1897-905, 1997.
, “Cytomegalovirus infections following renal transplantation-effects of antiviral prophylaxis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),”, Pediatr Nephro., vol. 11, pp. 665-71, 1997.
, “Cytomegalovirus infections following renal transplantation--effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Nephrol, vol. 11, no. 6, pp. 665-71, 1997.
, , , , , “Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation.”, J Am Soc Nephrol, vol. 8, no. 12, pp. 1930-41, 1997.
, , , “Fecal occult blood screening in the Minnesota study: role of chance detection of lesions.”, J Natl Cancer Inst, vol. 89, no. 19, pp. 1423-8, 1997.
, “Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test.”, J Natl Cancer Inst, vol. 89, pp. 1440-8, 1997.
, ,